Uss AS - Search Results

1

Current drug discovery strategies for treatment of hepatitis C virus infection.

Cheng KC, Gupta S, Wang H, Uss AS, Njoroge GF, Hughes E. Cheng KC, et al. Among authors: uss as. J Pharm Pharmacol. 2011 Jul;63(7):883-92. doi: 10.1111/j.2042-7158.2011.01267.x. Epub 2011 May 19. J Pharm Pharmacol. 2011. PMID: 21635253 Review.

2

Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors.

Li C, Nair L, Liu T, Li F, Pichardo J, Agrawal S, Chase R, Tong X, Uss AS, Bogen S, Njoroge FG, Morrison RA, Cheng KC. Li C, et al. Among authors: uss as. Biochem Pharmacol. 2008 Mar 1;75(5):1186-97. doi: 10.1016/j.bcp.2007.10.031. Epub 2007 Nov 7. Biochem Pharmacol. 2008. PMID: 18164692

3

Prediction of oral drug absorption in humans--from cultured cell lines and experimental animals.

Cheng KC, Li C, Uss AS. Cheng KC, et al. Among authors: uss as. Expert Opin Drug Metab Toxicol. 2008 May;4(5):581-90. doi: 10.1517/17425255.4.5.581. Expert Opin Drug Metab Toxicol. 2008. PMID: 18484916 Review.

4

Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans.

Li C, Liu T, Broske L, Brisson JM, Uss AS, Njoroge FG, Morrison RA, Cheng KC. Li C, et al. Among authors: uss as. Biochem Pharmacol. 2008 Dec 15;76(12):1757-64. doi: 10.1016/j.bcp.2008.09.005. Epub 2008 Sep 13. Biochem Pharmacol. 2008. PMID: 18835257

5

The role of P-glycoprotein in the pharmacokinetics and tissue distribution of a hepatitis C virus protease inhibitor.

Chen KX, Vibulbhan B, Liu T, Broske L, Wang G, Li C, Njoroge FG, Uss AS, Cheng KC. Chen KX, et al. Among authors: uss as. Drug Metab Lett. 2009 Dec;3(4):290-5. doi: 10.2174/187231209790218091. Drug Metab Lett. 2009. PMID: 19995330

6

Development of in vitro pharmacokinetic screens using Caco-2, human hepatocyte, and Caco-2/human hepatocyte hybrid systems for the prediction of oral bioavailability in humans.

Li C, Liu T, Cui X, Uss AS, Cheng KC. Li C, et al. Among authors: uss as. J Biomol Screen. 2007 Dec;12(8):1084-91. doi: 10.1177/1087057107308892. Epub 2007 Nov 7. J Biomol Screen. 2007. PMID: 17989424

7

Co-induction of CYP3A12 and 3A26 in dog liver slices by xenobiotics: species difference between human and dog CYP3A induction.

Chen J, Tran C, Xiao L, Palamanda J, Klapmuts T, Kumari P, Lin X, Wang EJ, Gu YZ, Humphries M, Uss AS, Cheng KC. Chen J, et al. Among authors: uss as. Drug Metab Lett. 2009 Jan;3(1):61-6. doi: 10.2174/187231209787176399. Drug Metab Lett. 2009. PMID: 19356119

8

Use of intrinsic clearance for prediction of human hepatic clearance.

Chao P, Uss AS, Cheng KC. Chao P, et al. Among authors: uss as. Expert Opin Drug Metab Toxicol. 2010 Feb;6(2):189-98. doi: 10.1517/17425250903405622. Expert Opin Drug Metab Toxicol. 2010. PMID: 20073997 Review.

9

De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.

Zhong W, Uss AS, Ferrari E, Lau JY, Hong Z. Zhong W, et al. Among authors: uss as. J Virol. 2000 Feb;74(4):2017-22. doi: 10.1128/jvi.74.4.2017-2022.2000. J Virol. 2000. PMID: 10644375 Free PMC article.

10

RNA-dependent RNA polymerase activity encoded by GB virus-B non-structural protein 5B.

Zhong W, Ingravallo P, Wright-Minogue J, Uss AS, Skelton A, Ferrari E, Lau JY, Hong Z. Zhong W, et al. Among authors: uss as. J Viral Hepat. 2000 Sep;7(5):335-42. doi: 10.1046/j.1365-2893.2000.00226.x. J Viral Hepat. 2000. PMID: 10971821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters